BR9813600A - Hidrato de sal de ácido malêico 5-[4-[2-(n-metil-n-(2-piridil) amino) etóxi]benzil]tiazolidina-2,4-diona como farmacêutico - Google Patents
Hidrato de sal de ácido malêico 5-[4-[2-(n-metil-n-(2-piridil) amino) etóxi]benzil]tiazolidina-2,4-diona como farmacêuticoInfo
- Publication number
- BR9813600A BR9813600A BR9813600-3A BR9813600A BR9813600A BR 9813600 A BR9813600 A BR 9813600A BR 9813600 A BR9813600 A BR 9813600A BR 9813600 A BR9813600 A BR 9813600A
- Authority
- BR
- Brazil
- Prior art keywords
- thiazolidine
- pyridyl
- amino
- methyl
- acid salt
- Prior art date
Links
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 title 1
- 150000004701 malic acid derivatives Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 2
- -1 N-METHYL-N- (2-PYRIDYL) AMINO Chemical class 0.000 abstract 1
- 238000001237 Raman spectrum Methods 0.000 abstract 1
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000002329 infrared spectrum Methods 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical class OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- SUFUKZSWUHZXAV-BTJKTKAUSA-N rosiglitazone maleate Chemical compound [H+].[H+].[O-]C(=O)\C=C/C([O-])=O.C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O SUFUKZSWUHZXAV-BTJKTKAUSA-N 0.000 abstract 1
- 238000000279 solid-state nuclear magnetic resonance spectrum Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726566.4A GB9726566D0 (en) | 1997-12-16 | 1997-12-16 | Novel pharmaceutical |
| PCT/EP1998/008155 WO1999031095A1 (en) | 1997-12-16 | 1998-12-14 | 5-[4-[2- (n-methyl-n- (2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9813600A true BR9813600A (pt) | 2000-10-10 |
Family
ID=10823692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9813600-3A BR9813600A (pt) | 1997-12-16 | 1998-12-14 | Hidrato de sal de ácido malêico 5-[4-[2-(n-metil-n-(2-piridil) amino) etóxi]benzil]tiazolidina-2,4-diona como farmacêutico |
Country Status (35)
| Country | Link |
|---|---|
| EP (2) | EP1661895A1 (OSRAM) |
| JP (1) | JP2002508373A (OSRAM) |
| KR (1) | KR100549142B1 (OSRAM) |
| CN (3) | CN1281453A (OSRAM) |
| AP (1) | AP1365A (OSRAM) |
| AR (1) | AR017214A1 (OSRAM) |
| AU (1) | AU1967999A (OSRAM) |
| BG (1) | BG64988B1 (OSRAM) |
| BR (1) | BR9813600A (OSRAM) |
| CA (1) | CA2314107A1 (OSRAM) |
| CO (1) | CO4980880A1 (OSRAM) |
| CZ (1) | CZ299965B6 (OSRAM) |
| DZ (1) | DZ2681A1 (OSRAM) |
| EA (1) | EA004260B1 (OSRAM) |
| EG (1) | EG22337A (OSRAM) |
| GB (1) | GB9726566D0 (OSRAM) |
| HR (1) | HRP20000408B1 (OSRAM) |
| HU (1) | HUP0100509A3 (OSRAM) |
| IL (1) | IL136424A (OSRAM) |
| IN (1) | IN192487B (OSRAM) |
| MA (1) | MA26580A1 (OSRAM) |
| MY (1) | MY135612A (OSRAM) |
| NO (1) | NO317254B1 (OSRAM) |
| OA (1) | OA11766A (OSRAM) |
| PE (1) | PE20000058A1 (OSRAM) |
| PL (1) | PL341146A1 (OSRAM) |
| RS (1) | RS50126B (OSRAM) |
| SA (1) | SA99191115B1 (OSRAM) |
| SK (1) | SK286618B6 (OSRAM) |
| TR (2) | TR200001799T2 (OSRAM) |
| TW (1) | TW509690B (OSRAM) |
| UA (1) | UA72198C2 (OSRAM) |
| UY (2) | UY25308A1 (OSRAM) |
| WO (1) | WO1999031095A1 (OSRAM) |
| ZA (1) | ZA9811506B (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726568D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| GB9909041D0 (en) * | 1999-04-20 | 1999-06-16 | Smithkline Beecham Plc | Novel pharmaceutical |
| PL351684A1 (en) * | 1999-04-23 | 2003-06-02 | Smithkline Beecham Plc | Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt |
| AU765498B2 (en) * | 1999-04-23 | 2003-09-18 | Smithkline Beecham Plc | Novel pharmaceutical |
| HK1045152A1 (zh) * | 1999-04-23 | 2002-11-15 | Smithkline Beecham Plc | 噻唑烷二酮衍生物及其用作抗糖尿病藥的應用 |
| HUP0300475A3 (en) * | 2000-04-25 | 2004-10-28 | Kyorin Seiyaku Kk | Novel stable crystal of thiazolidinedione derivative and process for producing the same |
| GB0014005D0 (en) * | 2000-06-08 | 2000-08-02 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021784D0 (en) * | 2000-09-05 | 2000-10-18 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021978D0 (en) * | 2000-09-07 | 2000-10-25 | Smithkline Beecham Plc | Novel pharmaceutical |
| AU2001291232B8 (en) * | 2000-09-26 | 2006-12-21 | Dr. Reddy's Laboratories Limited | Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
| MXPA03002580A (es) * | 2000-09-26 | 2003-10-15 | Cord Janet I | Nuevas formas polimorficas de maleato de 5-(4-(2-(n-metil-n-(2-piridil) amino)etoxi)bencil) tiazolidin-2, 4-diona y proceso para su preparacion. |
| GB0129876D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0129872D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
| AU2002350965A1 (en) * | 2001-12-13 | 2003-06-23 | Smithkline Beecham Plc | Toluenesulfonate hydrates of a thiazolidinedione derivative |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| EP2184055A1 (en) | 2008-11-07 | 2010-05-12 | LEK Pharmaceuticals d.d. | Process for preparing solid dosage forms of rosiglitazone maleate |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE186724T1 (de) * | 1987-09-04 | 1999-12-15 | Beecham Group Plc | Substituierte thiazolidindionderivate |
| GB8820389D0 (en) * | 1988-08-26 | 1988-09-28 | Beecham Group Plc | Novel compounds |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| JPH09512249A (ja) * | 1994-02-10 | 1997-12-09 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 腎臓疾患を治療するためのインスリンセンシタイザーの使用 |
-
1997
- 1997-12-16 GB GBGB9726566.4A patent/GB9726566D0/en not_active Ceased
-
1998
- 1998-12-14 CN CN98812089A patent/CN1281453A/zh active Pending
- 1998-12-14 MA MA25389A patent/MA26580A1/fr unknown
- 1998-12-14 CN CNA200810087031XA patent/CN101381367A/zh active Pending
- 1998-12-14 BR BR9813600-3A patent/BR9813600A/pt not_active Application Discontinuation
- 1998-12-14 TR TR2000/01799T patent/TR200001799T2/xx unknown
- 1998-12-14 UA UA2000063485A patent/UA72198C2/uk unknown
- 1998-12-14 CA CA002314107A patent/CA2314107A1/en not_active Abandoned
- 1998-12-14 JP JP2000539019A patent/JP2002508373A/ja not_active Withdrawn
- 1998-12-14 AU AU19679/99A patent/AU1967999A/en not_active Abandoned
- 1998-12-14 EP EP05077331A patent/EP1661895A1/en not_active Withdrawn
- 1998-12-14 EA EA200000654A patent/EA004260B1/ru not_active IP Right Cessation
- 1998-12-14 KR KR1020007006515A patent/KR100549142B1/ko not_active Expired - Fee Related
- 1998-12-14 PL PL98341146A patent/PL341146A1/xx not_active Application Discontinuation
- 1998-12-14 OA OA1200000178A patent/OA11766A/en unknown
- 1998-12-14 EP EP98964510A patent/EP1040110A1/en not_active Withdrawn
- 1998-12-14 CZ CZ20002204A patent/CZ299965B6/cs not_active IP Right Cessation
- 1998-12-14 HR HR20000408A patent/HRP20000408B1/xx not_active IP Right Cessation
- 1998-12-14 WO PCT/EP1998/008155 patent/WO1999031095A1/en not_active Ceased
- 1998-12-14 AP APAP/P/2000/001831A patent/AP1365A/en active
- 1998-12-14 SK SK917-2000A patent/SK286618B6/sk not_active IP Right Cessation
- 1998-12-14 CN CNA2008100870305A patent/CN101302215A/zh active Pending
- 1998-12-14 HU HU0100509A patent/HUP0100509A3/hu unknown
- 1998-12-14 IL IL13642498A patent/IL136424A/xx unknown
- 1998-12-14 RS YUP-363/00A patent/RS50126B/sr unknown
- 1998-12-15 EG EG155698A patent/EG22337A/xx active
- 1998-12-15 DZ DZ980291A patent/DZ2681A1/xx active
- 1998-12-15 ZA ZA9811506A patent/ZA9811506B/xx unknown
- 1998-12-15 UY UY25308A patent/UY25308A1/es not_active IP Right Cessation
- 1998-12-15 AR ARP980106370A patent/AR017214A1/es unknown
- 1998-12-15 MY MYPI98005674A patent/MY135612A/en unknown
- 1998-12-15 UY UY25304A patent/UY25304A1/es unknown
- 1998-12-16 PE PE1998001233A patent/PE20000058A1/es not_active Application Discontinuation
- 1998-12-16 CO CO98074834A patent/CO4980880A1/es unknown
- 1998-12-16 TR TR1998/02625A patent/TR199802625A3/tr unknown
- 1998-12-16 TW TW087121121A patent/TW509690B/zh not_active IP Right Cessation
- 1998-12-16 IN IN3772DE1998 patent/IN192487B/en unknown
-
1999
- 1999-02-27 SA SA99191115A patent/SA99191115B1/ar unknown
-
2000
- 2000-06-15 NO NO20003069A patent/NO317254B1/no not_active IP Right Cessation
- 2000-07-13 BG BG104603A patent/BG64988B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9813598A (pt) | Derivado de tiazolidinediona substituìdo, processo para a sua preparação e seu uso farmacêutico | |
| BR0009934A (pt) | Produto farmacêutico | |
| BR9813604A (pt) | Hidrato de sal de ácido maleico 5-[4-[2- (n-metil-n-(2-piridil) amino) etóxi]benzil]tiazolidina-2,4-diona | |
| EA200000654A1 (ru) | Гидрат соли малеиновой кислоты 5-[4-[2-(n-метил-n-(2-пиридил)амино) этокси]бензил]-тиазолидин-2,4-диона в качестве фармацевтического препарата | |
| IL78831A (en) | 6-(thiazolidin-2,4-dion-5-ylmethyl)chromans and structurally related compounds as hypoglycemic agents | |
| UY26121A1 (es) | Nuevo compuesto farmacéutico | |
| DE59208974D1 (de) | Neue pyrazinderivative, ihre herstellung und verwendung | |
| BR0009935A (pt) | Produto farmacêutico | |
| BR9810405A (pt) | Composição que compreende 5-[4-[2-(n-metil-n-2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona | |
| DE3769563D1 (de) | Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung. | |
| BR0009897A (pt) | Produto farmacêutico | |
| DE69130266D1 (de) | Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel | |
| BR0009898A (pt) | Produto farmacêutico | |
| DE60025171D1 (de) | 1-acyl-7-nitroindolin derivate, deren herstellung und deren verwendung als photospaltbare vorstufen | |
| ID30064A (id) | Kristal-kristal 5[(2-fluorobenzil) oksi-2-naftil) metil]-2, 4-tiazolidinedion | |
| ECSP982779A (es) | Un hidrato de la sal de acido maleico, proceso para la preparacion, composicion farmaceutica y su uso en medicina | |
| ECSP982781A (es) | Hidrato de la sal de maleico de 5-[4- (-n -metil-n- (2-piridil) amino) etoxi) bensil) tiazolidina - 2,4 diona | |
| GR3002884T3 (en) | Substituted chinoxalyl-imidazolidine-2,4-diones, process for their preparation, their use as medicaments and pharmacological preparations | |
| ECSP003436A (es) | Nuevos compuestos | |
| ECSP003438A (es) | Nuevos compuestos | |
| TH84544A (th) | ไฮเดรทชนิดใหม่ | |
| Garg et al. | New 2-nitroimidazole analogues of amino acids with a free amino function | |
| ECSP003434A (es) | Nuevos compuestos | |
| ECSP003437A (es) | Nuevos compuestos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO COM BASE NOS ARTIGOS 8O, 11 E 13 DA LEI 9279/96 |